Diagnostics & Research
The Diagnostics & Research industry has a total of 59 stocks, with a combined market cap of $781.96 billion, total revenue of $154.27 billion and a weighted average PE ratio of 58.04.
Market Cap
781.96B
Revenue
154.27B
Profits
13.47B
PE Ratio
58.04
Profit Margin
8.73%
Dividend Yield
0.20%
59 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 231.76B | 2.13% | 2,346,856 | 42.49B |
| 2 | DHR | Danaher Corporation | 197.82B | 1.41% | 2,802,626 | 21.11B |
| 3 | IQV | IQVIA Holdings Inc. | 43.69B | 3.18% | 1,195,031 | 15.16B |
| 4 | A | Agilent Technologies, Inc. | 40.06B | 1.73% | 1,482,999 | 6.59B |
| 5 | IDXX | IDEXX Laboratories, Inc. | 38.79B | -0.21% | 534,995 | 3.72B |
| 6 | MTD | Mettler-Toledo International Inc. | 30.97B | 2.77% | 134,480 | 3.79B |
| 7 | ICLR | ICON PLC | 26.74B | 3.31% | 908,078 | 8.33B |
| 8 | ILMN | Illumina, Inc. | 19.18B | 2.67% | 1,412,383 | 4.49B |
| 9 | WAT | Waters Corporation | 18.86B | 2.47% | 231,836 | 2.91B |
| 10 | LH | Labcorp Holdings Inc. | 17.78B | 0.56% | 395,617 | 12.30B |
| 11 | DGX | Quest Diagnostics Incorporated | 16.21B | 0.93% | 1,282,555 | 9.35B |
| 12 | RVTY | Revvity, Inc. | 14.21B | 2.07% | 1,380,390 | 2.73B |
| 13 | NTRA | Natera, Inc. | 12.61B | 0.51% | 920,132 | 1.21B |
| 14 | CRL | Charles River Laboratories International, Inc. | 12.03B | 5.26% | 553,475 | 4.11B |
| 15 | MEDP | Medpace Holdings, Inc. | 11.83B | 0.25% | 392,734 | 2.03B |
| 16 | QGEN | Qiagen N.V. | 9.75B | 4.02% | 1,371,075 | 1.94B |
| 17 | EXAS | Exact Sciences Corporation | 8.36B | -6.33% | 3,682,363 | 2.53B |
| 18 | RDNT | RadNet, Inc. | 4.58B | 0.02% | 514,559 | 1.66B |
| 19 | GH | Guardant Health, Inc. | 4.04B | 3.35% | 1,159,690 | 603.73M |
| 20 | SHC | Sotera Health Company | 3.91B | 1.47% | 557,170 | 1.08B |
| 21 | NEOG | Neogen Corporation | 3.75B | 1.82% | 1,707,006 | 929.24M |
| 22 | TWST | Twist Bioscience Corporation | 3.38B | 0.99% | 666,226 | 277.49M |
| 23 | MYGN | Myriad Genetics, Inc. | 2.50B | -0.72% | 1,388,230 | 774.20M |
| 24 | NEO | NeoGenomics, Inc. | 1.90B | -1.33% | 833,402 | 610.66M |
| 25 | VCYT | Veracyte, Inc. | 1.81B | -0.17% | 476,451 | 375.47M |
| 26 | OPK | OPKO Health, Inc. | 1.03B | 4.23% | 2,876,009 | 799.60M |
| 27 | CDNA | CareDx, Inc | 990.11M | 0.74% | 1,190,804 | 275.11M |
| 28 | FLGT | Fulgent Genetics, Inc. | 708.01M | 2.91% | 138,082 | 287.53M |
| 29 | CSTL | Castle Biosciences, Inc. | 581.41M | 9.06% | 492,180 | 250.73M |
| 30 | GRAL | GRAIL, LLC | 506.72M | 3.00% | 634,634 | - |
| 31 | ME | 23andMe Holding Co. | 222.84M | -1.76% | 1,463,923 | 219.64M |
| 32 | BDSX | Biodesix, Inc. | 197.26M | 3.61% | 58,937 | 54.85M |
| 33 | PSNL | Personalis, Inc. | 179.19M | 20.63% | 1,862,999 | 74.15M |
| 34 | FONR | FONAR Corporation | 117.26M | 0.22% | 5,440 | 102.72M |
| 35 | ACRS | Aclaris Therapeutics, Inc. | 99.06M | 2.96% | 402,046 | 31.12M |
| 36 | TTOO | T2 Biosystems, Inc. | 78.21M | 5.38% | 77,881 | 7.18M |
| 37 | MDXH | MDxHealth SA | 75.04M | 3.44% | 19,655 | 75.33M |
| 38 | PRE | Prenetics Global Limited | 72.08M | 2.42% | 29,773 | 10.61M |
| 39 | BNR | Burning Rock Biotech Limited | 66.38M | - | 362 | 72.30M |
| 40 | VNRX | VolitionRx Limited | 62.94M | 10.00% | 92,287 | 797.03K |
| 41 | PRPH | ProPhase Labs, Inc. | 61.43M | 6.27% | 12,384 | 28.72M |
| 42 | ENZ | Enzo Biochem, Inc. | 59.18M | 0.88% | 53,740 | 4.72M |
| 43 | STIM | Neuronetics, Inc. | 56.70M | - | 92,583 | 73.23M |
| 44 | NOTV | Inotiv, Inc. | 50.90M | -1.01% | 133,782 | 552.74M |
| 45 | OCX | OncoCyte Corporation | 44.70M | - | 27,496 | 1.38M |
| 46 | XGN | Exagen Inc. | 34.92M | 1.52% | 11,501 | 55.73M |
| 47 | BIAF | bioAffinity Technologies, Inc. | 31.59M | 1.12% | 115,371 | 4.94M |
| 48 | AWH | Aspira Women's Health Inc. | 21.27M | -0.67% | 44,969 | 8.99M |
| 49 | STRR | Star Equity Holdings, Inc. | 14.93M | -3.26% | 2,854 | 42.56M |
| 50 | PMD | Psychemedics Corporation | 11.91M | -3.25% | 2,945 | 21.60M |
| 51 | CHEK | Check-Cap Ltd. | 11.76M | -0.50% | 3,460 | - |
| 52 | CNTG | Centogene N.V. | 9.86M | 2.72% | 69,275 | 53.93M |
| 53 | XWEL | XWELL, Inc. | 8.70M | -9.51% | 38,371 | 31.77M |
| 54 | PRPO | Precipio, Inc. | 8.14M | 7.65% | 17,076 | 15.81M |
| 55 | MYNZ | Mainz Biomed B.V. | 7.35M | -4.06% | 1,196,752 | 895.48K |
| 56 | NDRA | ENDRA Life Sciences Inc. | 5.61M | 3.06% | 2,803,921 | - |
| 57 | GENE | Genetic Technologies Limited | 4.32M | 3.69% | 68,505 | 5.78M |
| 58 | ISPC | iSpecimen Inc. | 3.72M | -0.28% | 841,550 | 9.27M |
| 59 | APDN | Applied DNA Sciences, Inc. | 3.70M | -1.49% | 272,446 | 5.52M |